Charles Schwab’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $106M | Sell |
467,663
-1,304
| -0.3% | -$232K | 0.01% | 761 |
|
|
2026
Q1 | $80.9M | Buy |
468,967
+14,814
| +3% | +$2.75M | 0.01% | 848 |
|
|
2025
Q4 | $90.6M | Sell |
454,153
-21,889
| -5% | -$3.97M | 0.01% | 778 |
|
|
2025
Q3 | $74.5M | Sell |
476,042
-69,707
| -13% | -$11.1M | 0.01% | 886 |
|
|
2025
Q2 | $82.8M | Sell |
545,749
-31,573
| -5% | -$4.21M | 0.01% | 767 |
|
|
2025
Q1 | $86.9M | Buy |
577,322
+24,347
| +4% | +$4.08M | 0.02% | 721 |
|
|
2024
Q4 | $102M | Buy |
552,975
+37,753
| +7% | +$7.27M | 0.02% | 661 |
|
|
2024
Q3 | $101M | Buy |
515,222
+32,311
| +7% | +$6.71M | 0.02% | 643 |
|
|
2024
Q2 | $99.8M | Buy |
482,911
+34,102
| +8% | +$7.73M | 0.02% | 654 |
|
|
2024
Q1 | $122M | Sell |
448,809
-64,418
| -13% | -$15.4M | 0.03% | 522 |
|
|
2023
Q4 | $121M | Buy |
513,227
+21,028
| +4% | +$4.14M | 0.03% | 474 |
|
|
2023
Q3 | $96.5M | Buy |
492,199
+11,053
| +2% | +$2.27M | 0.03% | 515 |
|
|
2023
Q2 | $101M | Buy |
481,146
+7,177
| +2% | +$1.43M | 0.03% | 511 |
|
|
2023
Q1 | $95.7M | Buy |
473,969
+10,364
| +2% | +$2.35M | 0.03% | 520 |
|
|
2022
Q4 | $101M | Buy |
463,605
+22,438
| +5% | +$4.9M | 0.03% | 478 |
|
|
2022
Q3 | $86.8M | Buy |
441,167
+134,509
| +44% | +$29M | 0.03% | 488 |
|
|
2022
Q2 | $65.6M | Buy |
306,658
+18,733
| +7% | +$4.58M | 0.02% | 616 |
|
|
2022
Q1 | $81.8M | Buy |
287,925
+13,865
| +5% | +$4.28M | 0.02% | 597 |
|
|
2021
Q4 | $103M | Sell |
274,060
-316
| -0.1% | -$123K | 0.03% | 517 |
|
|
2021
Q3 | $113M | Sell |
274,376
-103,186
| -27% | -$42.9M | 0.04% | 440 |
|
|
2021
Q2 | $140M | Buy |
377,562
+94,810
| +34% | +$31.7M | 0.05% | 370 |
|
|
2021
Q1 | $82M | Sell |
282,752
-14,976
| -5% | -$4.16M | 0.03% | 563 |
|
|
2020
Q4 | $74.4M | Sell |
297,728
-3,164
| -1% | -$754K | 0.03% | 554 |
|
|
2020
Q3 | $68.1M | Sell |
300,892
-113,749
| -27% | -$23.6M | 0.03% | 488 |
|
|
2020
Q2 | $72.3M | Sell |
414,641
-5,077
| -1% | -$810K | 0.04% | 468 |
|
|
2020
Q1 | $53M | Buy |
419,718
+22,020
| +6% | +$3.3M | 0.03% | 503 |
|
|
2019
Q4 | $60.8M | Buy |
397,698
+7,933
| +2% | +$1.1M | 0.03% | 522 |
|
|
2019
Q3 | $51.6M | Buy |
389,765
+30,884
| +9% | +$4.14M | 0.03% | 560 |
|
|
2019
Q2 | $50.9M | Sell |
358,881
-101,910
| -22% | -$13.8M | 0.03% | 555 |
|
|
2019
Q1 | $66.9M | Buy |
460,791
+67,125
| +17% | +$8.82M | 0.04% | 408 |
|
|
2018
Q4 | $44.6M | Sell |
393,666
-4,217
| -1% | -$528K | 0.03% | 501 |
|
|
2018
Q3 | $53.5M | Buy |
397,883
+15,301
| +4% | +$1.89M | 0.04% | 499 |
|
|
2018
Q2 | $42.9M | Buy |
382,582
+80,519
| +27% | +$8.7M | 0.03% | 565 |
|
|
2018
Q1 | $32.2M | Buy |
302,063
+12,670
| +4% | +$1.37M | 0.03% | 695 |
|
|
2017
Q4 | $31.7M | Buy |
289,393
+6,628
| +2% | +$721K | 0.03% | 665 |
|
|
2017
Q3 | $30.5M | Buy |
282,765
+15,562
| +6% | +$1.6M | 0.03% | 633 |
|
|
2017
Q2 | $27M | Buy |
267,203
+4,865
| +2% | +$448K | 0.03% | 649 |
|
|
2017
Q1 | $23.6M | Buy |
262,338
+19,716
| +8% | +$1.67M | 0.02% | 723 |
|
|
2016
Q4 | $18.5M | Sell |
242,622
-156,186
| -39% | -$11.9M | 0.02% | 801 |
|
|
2016
Q3 | $33.2M | Sell |
398,808
-39,080
| -9% | -$3.28M | 0.04% | 473 |
|
|
2016
Q2 | $36.2M | Sell |
437,888
-51,970
| -11% | -$4.28M | 0.05% | 406 |
|
|
2016
Q1 | $37.2M | Sell |
489,858
-50,704
| -9% | -$3.75M | 0.05% | 374 |
|
|
2015
Q4 | $43.5M | Sell |
540,562
-58,221
| -10% | -$4.2M | 0.06% | 314 |
|
|
2015
Q3 | $38.1M | Buy |
598,783
+31,065
| +5% | +$2.23M | 0.06% | 326 |
|
|
2015
Q2 | $39.9M | Buy |
567,718
+160,154
| +39% | +$11.9M | 0.06% | 337 |
|
|
2015
Q1 | $32.3M | Buy |
407,564
+276,502
| +211% | +$20.4M | 0.05% | 403 |
|
|
2014
Q4 | $8.34M | Sell |
131,062
-27,419
| -17% | -$1.72M | 0.01% | 1025 |
|
|
2014
Q3 | $9.47M | Sell |
158,481
-36,735
| -19% | -$2.1M | 0.02% | 873 |
|
|
2014
Q2 | $10.4M | Sell |
195,216
-938
| -0.5% | -$51.5K | 0.02% | 800 |
|
|
2014
Q1 | $11.8M | Buy |
196,154
+75,882
| +63% | +$4.42M | 0.02% | 685 |
|
|
2013
Q4 | $6.38M | Sell |
120,272
-87,900
| -42% | -$4.41M | 0.01% | 1065 |
|
|
2013
Q3 | $9.69M | Sell |
208,172
-70,852
| -25% | -$3.25M | 0.02% | 662 |
|
|
2013
Q2 | $11.6M | Buy |
+279,024
| New | +$12M | 0.03% | 517 |
|
Other funds holding CRL
AI
Charles Schwab's CRL Position: Q2 2026 in Review
Charles Schwab reduced its Charles River Laboratories (CRL) stake by 0.28% in Q2 2026, selling an estimated $232K and leaving 467,663 shares worth $106M. The position accounts for 0.01% of the portfolio, ranked #761.
Charles Schwab first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $140M in Q2 2021. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Charles Schwab held 467,663 shares of Charles River Laboratories worth $106M as of Q2 2026.
- Charles Schwab sold 1,304 Charles River Laboratories shares in Q2 2026, an estimated $232K.
- Charles River Laboratories made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #761 holding.
- Charles Schwab first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Charles River Laboratories position peaked at $140M in Q2 2021.
- 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.